Luxury Time Ltd. IPO Allotment Status: Check Overall Subscription & Steps to Verify Status

The IPO allotment process for Luxury Time Ltd. is expected to be finalised today, i.e. December 9, 2025. The IPO opened for subscription on December 4, 2025, and closed on December 8, 2025. The Luxury Time Ltd. IPO is a ₹18.74 crore book build issue that combines a fresh issue of 0.18 crore shares and an OFS (offer-for-sale) of 0.05 crore shares. The IPO will list on BSE SME, with a tentative listing date of December 11, 2025. 

Here’s how you can check Luxury Time Ltd. IPO Allotment Status on BSE and the registrar’s website. 

Procedure to Check Luxury Time Ltd. IPO Allotment Status Online On BSE

• Click here to visit the application status page. 
• In Issue Type, “Equity”.
• In Issue Name, select “Luxury Time Ltd.”
• Enter your “Application No.” or “PAN No.”
• Click on “I am not a robot”.
• Click “Submit”.

Procedure to Check Luxury Time Ltd. IPO Allotment Status on MAS Services Ltd. (Registrar to the issue)

• Click here to visit the MAS Services Ltd. application status page.
• You will see a list of IPOs at the registrar, along with their allotment status. 
• Once it is released, you can click it to view the necessary details. 

Luxury Time Ltd. IPO Details

• Issue Type: Luxury Time Ltd. IPO is a book build issue of ₹18.74 crore, inclusive of a fresh issue of 0.18 crore shares aggregating to ₹15.00 crore. There is also an offer-for-sale of 0.05 crore shares, which cumulatively amount to ₹3.74 crore. 
• Price Band: The price band for the Luxury Time Ltd. IPO is set at ₹78.00 to ₹82.00 per share, with a lot size of 1,600. 
• Minimum Investment Amount: The minimum investment amount needed by retail investors is ₹2,62,400.00 or 3,200 shares (based on the upper price). The minimum lot size for HNIs is 3 lots or 4,800 shares, totalling ₹3,93,600.
• Book Running Lead Manager: GYR Capital Advisors Pvt. Ltd.
• Registrar: MAS Services Ltd.
• Market Maker: Giriraj Stock Broking Pvt. Ltd. 

Luxury Time Ltd. IPO Overall Subscription Status

08 December 2025, end of day

The Luxury Time Ltd. IPO saw an overall subscription of 635.53 times as per the BSE data as of (date). The public issue was subscribed:

• 205.58 times by Qualified Institutional Buyers (QIBs)
• 676.95 times by Non-Institutional Investors (NIIs)
• 860.53 times by Retail Individual Investors (RIIs)

Explore other Upcoming IPOs on BSE and NSE.

Utilisation of Proceeds

The company plans to utilise the net proceeds from the fresh issue towards:

• ₹2.82 crore- funding capital expenditure towards setting up of 04 new retail stores
• ₹9 crore- funding working capital requirements 
• General corporate purposes 

Check out newly Listed IPOs on BSE and NSE.

About Luxury Time Ltd.

Founded in 2008, Luxury Time Ltd. is a company that distributes, manufactures, and retails Swiss luxury watches and provides after-sales servicing for them. It is also involved in distributing watch service-related equipment and tools in India. Headquartered in New Delhi, it functions across five business verticals: B2B watch distribution; D2C and e-commerce retail; after-sales services; branding, PR, and marketing support; and tools and machinery distribution. The brand has 70+ POS (points of sale) throughout the country, including multi-brand outlets, digital platforms, and mono-brand boutiques. It has a presence in leading cities like Delhi, Mumbai, Bengaluru, Kolkata, Hyderabad, Chennai, Ahmedabad, and several other Tier 1 and 2 cities in India. 

The financials reported by the company are the following: 

• ₹29.87 crore in assets, as of 30 September 2025
• The company’s revenues increased by 20% between the financial year ending March 31, 2025, and March 31, 2024. PAT (profit after tax) also rose by 114% in the same period
• ₹24.91 crore in total income and ₹2.01 crore in PAT for this period, along with EBITDA of ₹294 crore. 
• The company's total borrowings stood at ₹2.07 crore as of 30 September 2025.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here